BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology
German independent research institute BioMed X announces the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research project RNA Splicing in...
New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that its VP3 multidose device is the delivery...
Cryoport and Cell Matters Enter into Strategic Partnership
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that it has entered into a strategic partnership...
Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent stem cell (“iPSC”)-based disease...
Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the...
Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic Goods Administration (TGA) has...
EC Approves Merck’s KEYTRUDA as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma Following Surgery
Merck, known as MSD outside the United States and Canada, announced that the EC has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...